NUTXNasdaqServices-Business Services, NECFiscal year ends December 31

Nutex Health Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$191.25+5.15 (+2.77%)

Close on Oct 19, 2026

Market cap: $1.34B
P/E (TTM): 7.5
Dividend yield: –

Nutex Health Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31
Revenue	875	480	248	219	332	274	1.37	1.37	0.02	0	0.47	1.07	1.46	1.59	1.78	0.87
Cost of Revenue	–	–	–	–	15	0.91	0.83	0.51	0.03	0	0.01	0.47	0.50	0.78	0.76	0.39
Gross Profit	444	196	35	15	179	158	0.54	0.86	-0.01	0	0.47	0.60	0.97	0.81	1.02	0.48
Research & Development	–	–	–	–	0.29	0.56	0.77	0.55	–	–	–	–	–	–	–	–
Selling, General & Admin	–	–	–	–	–	4.60	4.24	1.15	–	–	–	–	–	–	–	–
Selling & Marketing	–	–	–	–	–	0.17	0.58	0.21	–	–	–	–	–	–	–	–
General & Administrative	52	42	33	20	5.46	4.43	3.67	0.95	1.81	0.45	0.53	0.72	1.69	2.38	1.86	1.83
Advertising Expenses	6.50	5.60	5.50	–	0.02	0.04	0.12	0	0.00	0	–	–	–	0.03	0.02	–
Operating Expenses	169	66	67	422	9.02	4.43	7.43	1.70	5.69	0.45	–	–	–	–	–	–
Total Costs & Expenses	431	284	213	204	152	116	–	–	–	–	–	–	–	–	–	–
Operating Income	276	131	-32	-407	170	153	-6.90	-0.84	-5.69	-0.45	-0.53	-0.72	-0.73	-1.57	-0.84	-1.35
Interest Expense	22	20	16	12	6.20	6.43	0.09	0.11	0.37	0.00	0.00	0.00	-0.05	–	–	–
Interest & Investment Income	–	–	–	–	0.00	0.00	0.00	0.00	0	0.00	–	–	–	–	–	–
Other Non-Operating Income	-8.62	0.67	-0.40	-0.56	5.42	-1.00	-0.22	-0.11	-0.31	0.00	0.00	0.08	0.66	0.04	0.03	–
Asset Impairment Charges	0	3.20	1.14	398	0	3.47	2.26	–	–	–	–	–	–	0.11	–	–
Gain (Loss) on Investments	–	–	–	–	5.89	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	0	0.14	0	–	6.66	–	0.01	–	–	–	–	–
Pretax Income	245	110	-48	-420	169	146	-7.12	–	–	–	-0.54	-0.64	-0.07	-1.53	-0.82	-1.34
Income Tax Expense	64	15	-5.07	13	0.97	0.18	0	0	–	–	–	–	–	–	–	–
Income from Continuing Operations	–	–	–	–	14	5.53	-7.12	-2.81	-6.01	-0.45	-0.54	-0.70	-0.07	-1.62	-0.55	-0.84
Income from Discontinued Operations	–	–	–	–	0	-0.12	0	0	6.59	-6.98	0.62	-0.05	0.32	–	0.16	1.00
Net Income incl. Noncontrolling Interests	180	95	-43	-433	169	146	-7.12	-0.95	0.58	-7.43	0.08	-0.68	0.25	-1.62	-0.38	0.16
Minority Interest in Earnings	110	43	2.36	-7.96	36	40	–	–	–	–	–	–	–	–	–	–
Net Income	71	52	-46	-425	133	106	-7.12	-0.95	0.58	-7.43	0.08	-0.68	0.25	-1.62	-0.38	0.16
Net Income to Common	71	52	-46	-425	14	5.65	–	–	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	11.13	10.23	-10.39	-5.02	33.00	27.00	-14.70	-4.20	750.00	-712.50	0.00	-112.50	-37.50	-262.50	-75.00	37.50
EPS (Diluted)(per share)	10.48	9.69	-10.39	-5.02	33.00	27.00	-14.70	-4.20	750.00	-712.50	0.00	-112.50	-37.50	-262.50	-75.00	37.50
Shares Outstanding (Basic, Weighted)(shares)	6.36	5.09	4.41	85	3.95	3.95	0.48	0.23	0.00	0.01	–	–	–	–	–	–
Shares Outstanding (Diluted, Weighted)(shares)	6.76	5.49	4.41	85	3.95	0.66	0.48	0.23	0.00	0.01	0.01	0.01	0.01	0.01	–	–
EBITDA	296	150	-14	-393	178	159	-6.74	-0.84	–	–	–	-0.66	-0.69	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 51.3%
Operating margin: 43.0%
Net margin: 21.2%
Return on equity, FY2025: 30.7%

Financial strength

Current ratio: 5.00
Debt to equity: 0.10
Debt to assets: 4.1%
Cash to current liabilities: 175.1%

Valuation

P/E ratio: 7.5
Price to sales: 1.59
Price to book: 3.41
Dividend yield: –